India’s obesity crisis fuels a $2.6 bn drug race as pharma firms rush to launch affordable semaglutide generics, aiming to ...

Advances recognized by science’s most lucrative awards include high-energy physics experiments and groundbreaking weight-loss ...

The Trump administration rejected a proposed rule to allow Medicare to cover blockbuster obesity drugs for weight loss alone ...

Eli Lilly has launched weight-loss drug Mounjaro in India, priced at Rs 3,500 per injection for a 2.5mg dose. Will high costs ...

The growing number of Australians with obesity is causing economic damage but should the taxpayer fund weight-loss drugs?

A popular weight-loss drug used by celebrities overseas has been approved by New Zealand’s medicine regulatory body, with its ...

Advances recognized by science’s most lucrative awards include Large Hadron Collider experiments and groundbreaking ...

Administration officials reversed a decision made during the Biden presidency that would have given millions of people access ...

Extending coverage for the medications through Medicare could cost $35 billion over nine years, a congressional analysis ...

Here's everything you need to know about the new weight loss medication being rolled out by the NHS to treat obesity.

LONDON/COPENHAGEN (Reuters) -Novo Holdings, the controlling shareholder of obesity drugmaker Novo Nordisk (NYSE: NVO ), ...

Lexicon Pharmaceuticals, headquartered in The Woodlands, announced it will exclusively license its drug LX9851 to the maker ...